Stock listing
Lang & Schwarz:A14156 LivaNova PLC Aktie
German listing (Lang & Schwarz) of LivaNova PLC · home listing NASDAQ:LIVN
Follow LivaNova PLC into a list and get an email when it puts out news.
Home listing price · NASDAQ:LIVN
$90.73 USD -3.81 (-4.0%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:LIVN
- Day range
- $90.15 – $93.16 USDNov 20, 2026
- Volume
- 536,657 sharesNov 20, 2026
- Market cap
- $5.00B USDAt the close on Nov 20, 2026 · price × 55.09M shares outstanding
- 52-week range
- $53.48 – $99.38 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $56.25M USDMedian day 579,200 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:LIVN · Home | $90.73 USD | -3.81 (-4.0%) | 536,657 | $91.61 | $93.16 | $90.15 | $94.54 | Close on Nov 20, 2026 |
| Frankfurt:LIA | €83.50 EUR | -4.00 (-4.6%) | — | €83.50 | €83.50 | €83.50 | €87.50 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:LIVN · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $90.73 | -3.81 | -4.0% | $91.61 | $93.16 | $90.15 | 536,657 | |
| $94.54 | +2.62 | +2.9% | $91.29 | $95.40 | $90.20 | 1,321,127 | |
| $91.92 | -0.52 | -0.6% | $92.73 | $93.64 | $91.63 | 573,603 | |
| $92.44 | +1.12 | +1.2% | $90.77 | $94.80 | $90.77 | 805,674 | |
| $91.32 | +1.12 | +1.2% | $90.47 | $92.31 | $88.63 | 742,275 | |
| $90.20 | -0.78 | -0.9% | $90.91 | $91.32 | $89.88 | 465,909 | |
| $90.98 | -0.16 | -0.2% | $90.58 | $91.54 | $90.24 | 652,684 | |
| $91.14 | -1.47 | -1.6% | $91.63 | $92.00 | $89.33 | 754,133 | |
| $92.61 | +2.62 | +2.9% | $92.00 | $93.25 | $91.11 | 628,608 | |
| $89.99 | -1.15 | -1.3% | $90.09 | $91.51 | $88.42 | 443,974 | |
| $91.14 | -3.05 | -3.2% | $93.77 | $94.22 | $88.81 | 1,242,578 | |
| $94.19 | +14.29 | +17.9% | $89.68 | $99.38 | $89.50 | 3,788,870 | |
| $79.90 | -0.31 | -0.4% | $80.40 | $81.87 | $79.56 | 946,612 | |
| $80.21 | +1.24 | +1.6% | $79.80 | $82.03 | $78.85 | 605,522 | |
| $78.97 | -2.28 | -2.8% | $81.38 | $82.87 | $78.41 | 575,594 | |
| $81.25 | +0.59 | +0.7% | $81.92 | $82.28 | $81.05 | 483,270 | |
| $80.66 | +0.28 | +0.3% | $79.88 | $81.92 | $79.88 | 550,582 | |
| $80.38 | -0.24 | -0.3% | $81.04 | $81.04 | $80.05 | 383,596 | |
| $80.62 | -0.28 | -0.3% | $80.90 | $81.58 | $79.68 | 362,373 | |
| $80.90 | -0.37 | -0.5% | $80.72 | $81.77 | $80.33 | 572,100 | |
| $81.27 | +2.83 | +3.6% | $78.70 | $81.42 | $78.35 | 523,000 | |
| $78.44 | -1.27 | -1.6% | $79.83 | $81.25 | $78.01 | 556,300 | |
| $79.71 | +1.57 | +2.0% | $78.86 | $80.69 | $78.85 | 583,800 | |
| $78.14 | +0.56 | +0.7% | $78.02 | $78.84 | $77.39 | 387,100 | |
| $77.58 | -0.92 | -1.2% | $78.69 | $79.31 | $77.18 | 774,000 | |
| $78.50 | +2.42 | +3.2% | $76.90 | $79.11 | $76.20 | 738,000 | |
| $76.08 | -0.29 | -0.4% | $75.82 | $77.28 | $75.13 | 464,600 | |
| $76.37 | -0.90 | -1.2% | $77.34 | $78.10 | $76.12 | 561,300 | |
| $77.27 | +0.88 | +1.2% | $76.12 | $77.35 | $75.99 | 1,029,600 | |
| $76.39 | +0.48 | +0.6% | $76.12 | $77.66 | $75.63 | 339,400 | |
| $75.91 | -0.02 | 0.0% | $75.45 | $76.25 | $74.23 | 467,200 | |
| $75.93 | +1.00 | +1.3% | $75.06 | $76.26 | $74.44 | 692,100 | |
| $74.93 | -1.50 | -2.0% | $76.80 | $76.80 | $74.58 | 424,500 | |
| $76.43 | +1.36 | +1.8% | $75.56 | $76.90 | $74.23 | 558,900 | |
| $75.07 | +0.37 | +0.5% | $75.68 | $76.77 | $74.64 | 528,500 | |
| $74.70 | -1.80 | -2.4% | $76.44 | $77.15 | $74.47 | 767,200 | |
| $76.50 | -0.49 | -0.6% | $77.11 | $77.11 | $75.40 | 970,700 | |
| $76.99 | -0.22 | -0.3% | $76.71 | $77.15 | $76.13 | 567,800 | |
| $77.21 | +0.58 | +0.8% | $76.13 | $77.66 | $75.47 | 570,700 | |
| $76.63 | +1.19 | +1.6% | $75.44 | $77.46 | $75.12 | 745,300 | |
| $75.44 | -1.72 | -2.2% | $77.26 | $77.45 | $74.11 | 1,056,400 | |
| $77.16 | -1.33 | -1.7% | $78.39 | $79.02 | $76.70 | 493,100 | |
| $78.49 | +0.32 | +0.4% | $79.19 | $80.19 | $78.18 | 640,500 | |
| $78.17 | +0.16 | +0.2% | $78.39 | $78.63 | $76.83 | 579,200 | |
| $78.01 | +0.22 | +0.3% | $77.34 | $78.44 | $76.78 | 1,377,500 | |
| $77.79 | -0.72 | -0.9% | $79.23 | $79.23 | $77.51 | 627,300 | |
| $78.51 | -0.96 | -1.2% | $79.56 | $80.63 | $77.69 | 693,600 | |
| $79.47 | -1.16 | -1.4% | $80.19 | $80.24 | $79.13 | 587,200 | |
| $80.63 | +2.45 | +3.1% | $78.70 | $80.77 | $78.30 | 552,000 | |
| $78.18 | 0.00 | 0.0% | $79.22 | $79.27 | $77.15 | 552,400 | |
| $78.18 | -0.75 | -1.0% | $78.11 | $78.88 | $77.37 | 425,900 | |
| $78.93 | -1.77 | -2.2% | $80.22 | $80.37 | $78.11 | 674,400 | |
| $80.70 | -1.22 | -1.5% | $81.44 | $81.83 | $80.16 | 473,000 | |
| $81.92 | +0.72 | +0.9% | $80.67 | $82.22 | $80.39 | 334,200 | |
| $81.20 | -1.20 | -1.5% | $83.50 | $83.52 | $80.81 | 694,100 | |
| $82.40 | +2.24 | +2.8% | $80.16 | $83.32 | $80.16 | 769,400 | |
| $80.16 | +0.35 | +0.4% | $79.57 | $80.63 | $78.49 | 585,400 | |
| $79.81 | -0.51 | -0.6% | $79.86 | $80.15 | $77.28 | 593,700 | |
| $80.32 | +0.29 | +0.4% | $80.10 | $80.77 | $79.43 | 466,000 | |
| $80.03 | +0.06 | +0.1% | $79.34 | $80.27 | $78.96 | 611,300 | |
| $79.97 | +0.56 | +0.7% | $79.83 | $80.03 | $77.63 | 733,400 | |
| $79.41 | +1.15 | +1.5% | $78.73 | $79.59 | $77.90 | 562,919 | |
| $78.26 | -0.48 | -0.6% | $78.65 | $80.00 | $78.00 | 823,214 | |
| $78.74 | +0.53 | +0.7% | $78.80 | $79.56 | $77.94 | 440,200 | |
| $78.21 | -2.63 | -3.3% | $80.00 | $80.81 | $77.90 | 418,800 |
- Ticker
- Lang & Schwarz:A14156
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- Lang & Schwarz
- Currency
- EUR
What changed lately
Latest news release · Nov 4, 2026
LivaNova Reports Third-Quarter 2026 Results; Raises Full-Year 2026 Revenue and Adjusted Diluted EPS Guidance
Latest earnings call · Nov 4, 2026
LivaNova (NASDAQ:LIVN) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Nov 4, 2026
Q3 2026 Earnings Presentation
Earnings · 30 slides
Latest news
LivaNova Reports Third-Quarter 2026 Results; Raises Full-Year 2026 Revenue and Adjusted Diluted EPS Guidance
Nov 4, 2026
Closed $94.19 (+17.9%) on Nov 4, 2026
Neuromodulation Publishes Full 36-Month CORE-VNS Results Demonstrating Sustained and Increasing Benefits of LivaNova’s VNS Therapy for Drug-Resistant Epilepsy
Oct 23, 2026
Closed $80.90 (-0.5%) on Oct 23, 2026
LivaNova to Present at UBS, Wolfe, Stifel, and Jefferies Healthcare Conferences in November
Oct 21, 2026
Closed $78.44 (-1.6%) on Oct 21, 2026
LivaNova to Announce Third-Quarter 2026 Results
Sep 23, 2026
Closed $77.16 (-1.7%) on Sep 23, 2026
LivaNova to Present at Morgan Stanley and Baird Healthcare Conferences in September
Sep 3, 2026
Closed $81.20 (-1.5%) on Sep 3, 2026
LivaNova to Announce Second-Quarter 2026 Results
Jun 24, 2026
Closed $79.95 (+1.6%) on Jun 24, 2026
LivaNova Demonstrates 84.5% Cumulative Response Rate with PolySync Programming in OSPREY Study for Obstructive Sleep Apnea
Jun 16, 2026
Closed $79.48 (-0.3%) on Jun 16, 2026
Jette Nygaard-Andersen Joins LivaNova Board as a New Director
Jun 11, 2026
Closed $79.94 (+2.0%) on Jun 11, 2026
LivaNova Appoints Anne Liddy as Chief Legal Officer
Jun 5, 2026
Closed $72.36 (-1.8%) on Jun 5, 2026
LivaNova Appoints Stefano Folli to Lead its Cardiopulmonary Business Unit
May 21, 2026
Closed $73.64 (-0.1%) on May 21, 2026
LivaNova PLC on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 24 in the last 12 months · 168 in all · newest Nov 4, 2026 · oldest 2019
- Calls
- 24 calls with a replay · 24 with a transcript · latest Nov 4, 2026
- Decks
- 39 decks · latest Nov 4, 2026
Where LivaNova PLC is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:LIVN · Home listing | NASDAQ | United States | USD |
| Tradegate:LIA | Tradegate | Germany | EUR |
| LS Exchange:A14156 | LS Exchange | Germany | EUR |
| Lang & Schwarz:A14156 · This page | Lang & Schwarz | Germany | EUR |
| gettex:LIA | gettex | Germany | EUR |
| BOATS:LIVN | BOATS | United States | USD |
| B3:L2IV34 | B3 | Brazil | BRL |
| Frankfurt:LIA | Frankfurt | Germany | EUR |
| Dusseldorf:LIA | Dusseldorf | Germany | EUR |
| Munich:LIA | Munich | Germany | EUR |
| Stuttgart:LIA | Stuttgart | Germany | EUR |
Valuation
P/E 25.5× against a median of 39.3×: 3rd lowest of 10 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $4.73B USD
- P/E
- 25.5×
- EV/sales
- 3.1×
- EV/EBITDA
- 21.6×
- Price/book
- 3.6×
- Gross margin
- 67.8%
- Operating margin
- 10.8%
- Net margin
- 13.0%
- Debt to equity
- 0.2×
- Beta vs S&P 500
- 1.02
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| LivaNova PLC · NASDAQ:LIVN | US$5.00B | US$4.73B | 25.5× | 3.1× | 21.6× | 3.6× | 13.0% | 0.2× | 1.02 |
| ConvaTec Group PLC · LSE:CTEC | US$6.64B | US$8.29B | 37.9× | 3.4× | 15.2× | 4.6× | 7.2% | 1.2× | n/a |
| Cochlear Limited · ASX:COH | US$6.49B | US$6.51B | 66.6× | 4.2× | 24.2× | 5.6× | 6.3% | 0.1× | n/a |
| APT Medical Inc. Class A · SSE:688617 | US$5.98B | US$5.72B | 39.3× | 12.4× | n/a | 11.8× | 33.0% | 0.0× | n/a |
| Haemonetics Corporation · NYSE:HAE | US$5.47B | US$6.35B | 52.7× | 4.6× | 22.1× | 6.1× | 7.5% | 1.3× | 0.27 |
| Merit Medical Systems, Inc. · NASDAQ:MMSI | US$5.05B | US$5.29B | 31.6× | 3.3× | 15.4× | 2.9× | 9.9% | 0.4× | 0.49 |
| Intco Medical Technology Co., Ltd. Class A · SZSE:300677 | US$4.73B | US$3.55B | 106× | 1.8× | n/a | 1.7× | 2.3% | 0.0× | n/a |
| MiniMed Group, Inc. · NASDAQ:MMED | US$4.50B | US$4.30B | n/a | n/a | n/a | 1.2× | n/a | 0.0× | 1.04 |
| ICU Medical, Inc. · NASDAQ:ICUI | US$4.31B | US$5.16B | 71.5× | 2.4× | 16.6× | 2.0× | 2.8% | 0.5× | 0.99 |
| Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Class A · SZSE:002223 | US$4.18B | US$3.97B | 24.3× | 3.3× | n/a | 2.2× | 14.3% | 0.0× | n/a |
| IMEIK Technology Development Co., Ltd. Class A · SZSE:300896 | US$3.67B | US$3.13B | 24.8× | 9.0× | n/a | 3.1× | 42.4% | 0.0× | n/a |
| Median of the others | US$4.89B | US$5.23B | 39.3× | 3.4× | 16.6× | 3.0× | 7.5% | 0.1× | 0.74 |
Forecasts
6 strong buy · 3 buy · 1 hold · 1 sell · Analysts' consensus from EODHD, read Nov 22, 2026. Not 6ix's view and not investment advice.
- Price target
- 106.36 USD · Analysts' mean
- EPS, year to Dec 2026
- 4.44 · 10 analysts
- Revenue, year to Dec 2026
- 1.53B · 10 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Vladimir Makatsaria | Chief Executive Officer |
| Alex Shvartsburg | Chief Financial Officer |
| Stefano Folli | President, Cardiopulmonary |
| Stephanie Bolton | President, Global Epilepsy |
| Anne Liddy | Chief Legal Officer |
| Briana Gotlin | Vice President, Investor Relations |
| Deanna Wilke | VP, Corporate Communications |
| Ahmet Tezel | Chief Innovation Officer |
| Lucile Blaise | Global Head of Commercialization, Obstructive Sleep Apnea |
| Natalia Kozmina | Chief Human Resources Officer |
| Philip Kowalczyk | Chief Strategy and Corporate Development Officer |
| Sujay Mashru | Senior Vice President, APAC and Growth Markets |
Board
| Director | Role |
|---|---|
| William Kozy | Chair of the Board |
| Brooke Story | Director since 2022 |
| Donald Zurbay | Director since 2025 |
| Francesco Bianchi | Director since 2015 |
| J. Christopher Barry | Director since 2023 |
| Jette Nygaard-Andersen | Director since 2026 |
| Peter Wilver | Director since 2022 |
| Stacy Enxing Seng | Director since 2019 |
| Susan Podlogar | Director since 2024 |
| Todd C. Schermerhorn | Director since 2020 |
| Vladimir Makatsaria | Chief Executive Officer |
Events
Calls
| Call | When | Status |
|---|---|---|
| LivaNova (NASDAQ:LIVN) Q3 2026 Earnings Call | Wed, Nov 04, 2026 · 8:00 AM ET | Replay |
| LivaNova (NASDAQ:LIVN) Q2 2026 Earnings Call | Wed, Aug 05, 2026 · 8:00 AM ET | Replay |
| LivaNova (NASDAQ:LIVN) Q1 2026 Earnings Call | Wed, May 06, 2026 · 8:00 AM ET | Replay |
| LivaNova (NASDAQ:LIVN) Q4 2025 Earnings Call | Wed, Feb 25, 2026 · 8:00 AM ET | Replay |
| LivaNova (NASDAQ:LIVN) Q3 2025 Earnings Call | Wed, Nov 05, 2025 · 8:00 AM ET | Replay |
| LivaNova (NASDAQ:LIVN) Q2 2025 Earnings Call | Wed, Aug 06, 2025 · 8:00 AM ET | Replay |
| LivaNova (NASDAQ:LIVN) Q1 2025 Earnings Call | Wed, May 07, 2025 · 8:00 AM ET | Replay |
| LivaNova (NASDAQ:LIVN) Q4 2024 Earnings Call | Tue, Feb 25, 2025 · 8:00 AM ET | Replay |
| LivaNova (NASDAQ:LIVN) Q3 2024 Earnings Call | Wed, Oct 30, 2024 · 8:00 AM ET | Replay |
| LivaNova (NASDAQ:LIVN) Q2 2024 Earnings Call | Wed, Jul 31, 2024 · 8:00 AM ET | Replay |
All 24 calls
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Nov 4, 2026 · Before open | +17.9% |
| Q2 2026 | Aug 5, 2026 · Before open | −8.4% |
| Q1 2026 | May 6, 2026 · Before open | +15.1% |
| Q4 2025 | Feb 25, 2026 | +2.8% |
| Q3 2025 | Nov 5, 2025 · Before open | −5.8% |
| Q2 2025 | Aug 6, 2025 · Before open | +11.2% |
| Q1 2025 | May 7, 2025 · Before open | +23.7% |
| Q4 2024 | Feb 19, 2025 · Before open | +0.6% |
| Q3 2024 | Oct 30, 2024 · Before open | −3.1% |
| Q2 2024 | Jul 31, 2024 · Before open | −3.7% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | May 1, 2024 · Before open | +12.3% |
| Q4 2023 | Feb 21, 2024 · Before open | +8.0% |
| Q3 2023 | Nov 1, 2023 · Before open | +2.0% |
| Q2 2023 | Jul 26, 2023 · Before open | +9.9% |
| Q1 2023 | May 3, 2023 · Before open | +0.8% |
| Q4 2022 | Feb 22, 2023 · Before open | −10.9% |
| Q3 2022 | Nov 2, 2022 · Before open | +3.1% |
| Q2 2022 | Aug 3, 2022 · Before open | −0.5% |
| Q1 2022 | May 4, 2022 · Before open | −1.0% |
| Q4 2021 | Feb 23, 2022 · Before open | +1.7% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q3 2026 Earnings Presentation | Earnings | 30 slides | Nov 4, 2026 |
| Q2 2026 Earnings Presentation | Earnings | 29 slides | Aug 5, 2026 |
| Q1 2026 Earnings Presentation | Earnings | 26 slides | May 6, 2026 |
| Q4 2025 Earnings Presentation | Earnings | 31 slides | Feb 25, 2026 |
| Q3 2025 Earnings Presentation | Earnings | 27 slides | Nov 5, 2025 |
| Q2 2025 Earnings Presentation | Earnings | 29 slides | Aug 6, 2025 |
| Q1 2025 Earnings Presentation | Earnings | 25 slides | May 7, 2025 |
| Q4 2024 Earnings Presentation | Earnings | 31 slides | Feb 25, 2025 |
| Q3 2024 Earnings Presentation | Earnings | 26 slides | Oct 30, 2024 |
| Q2 2024 Earnings Presentation | Earnings | 26 slides | Jul 31, 2024 |
All 39 decks
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.39B | 1.25B | 1.15B | 1.02B | 1.04B | 934.2M | 1.08B | 1.11B | 1.01B | 964.9M |
| Cost of revenue | 448.2M | 400.0M | 397.7M | 314.6M | 329.4M | 339.5M | 360.4M | 361.3M | 353.2M | 367.8M |
| Gross profit | 939.9M | 853.5M | 755.8M | 707.2M | 706.0M | 594.8M | 723.8M | 734.5M | 651.6M | 559.5M |
| Research and development | 185.8M | 182.5M | 193.8M | 155.8M | 183.4M | 152.9M | 146.8M | 145.9M | 109.5M | 82.1M |
| Selling, general and administrative | 548.8M | 508.9M | 502.7M | 469.2M | 471.9M | 446.6M | 528.5M | 465.0M | 380.1M | 355.2M |
| Operating income | 199.4M | 129.1M | -68.5M | -76.8M | -784.0K | -273.9M | -171.6M | -248.1M | 96.5M | 33.4M |
| Depreciation and amortization | 28.6M | 25.1M | 24.7M | 22.4M | 24.5M | 29.0M | 30.3M | 32.7M | 37.1M | 85.4M |
| EBITDA | 228.0M | 154.2M | -43.8M | -54.4M | 23.8M | -244.9M | -141.2M | -215.3M | 133.5M | 118.8M |
| Interest expense | 49.3M | 63.1M | 58.9M | 48.3M | 50.2M | 40.8M | 15.1M | 9.82M | 7.80M | 10.6M |
| Income before tax | -220.8M | 88.3M | -81.2M | -75.1M | -124.5M | -348.0M | -188.4M | -247.4M | 121.1M | 25.7M |
| Income tax | 21.6M | 25.1M | -98.9M | 11.1M | 11.2M | -960.0K | -30.4M | -69.6M | 50.0M | 5.11M |
| Net income | -242.5M | 63.2M | 17.5M | -86.2M | -135.8M | -348.8M | -157.6M | -189.4M | -25.1M | -62.8M |
| Earnings per share, basic | -4.45 | 1.17 | 0.33 | -1.61 | -2.68 | -7.18 | -3.21 | -3.91 | -0.52 | -1.29 |
| Earnings per share, diluted | -4.45 | 1.16 | 0.32 | -1.61 | -2.68 | -7.18 | -3.26 | -3.91 | -0.52 | -1.28 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 635.6M | 428.9M | 266.5M | 214.2M | 208.0M | 252.8M | 61.1M | 47.2M | 93.6M | 39.8M |
| Short-term investments | -34.0K | -2.00K | 31.1M | 2.65M | 2.94M | -8.00K | ||||
| Receivables | 216.0M | 193.2M | 215.1M | 183.1M | 185.4M | 184.4M | 257.8M | 256.1M | 282.1M | 213.3M |
| Inventory | 164.7M | 147.6M | 147.9M | 129.4M | 105.8M | 115.3M | 164.2M | 153.5M | 144.5M | 133.0M |
| Current assets | 1.10B | 1.13B | 988.2M | 886.1M | 679.2M | 708.0M | 549.4M | 533.3M | 869.9M | 812.7M |
| Property, plant and equipment | 242.6M | 170.3M | 154.2M | 147.2M | 150.1M | 163.8M | 181.4M | 191.4M | 192.4M | 203.7M |
| Goodwill | 792.8M | 750.0M | 782.9M | 768.8M | 899.5M | 922.3M | 915.8M | 956.8M | 784.2M | 691.7M |
| Total assets | 2.61B | 2.51B | 2.43B | 2.29B | 2.20B | 2.40B | 2.41B | 2.55B | 2.50B | 2.34B |
| Accounts payable | 97.2M | 69.7M | 80.8M | 74.3M | 68.0M | 73.7M | 85.9M | 76.7M | 85.9M | 71.9M |
| Current liabilities | 808.1M | 392.1M | 335.0M | 297.4M | 697.0M | 309.1M | 512.6M | 496.7M | 406.0M | 349.9M |
| Long-term debt | 345.2M | 549.6M | 568.5M | 518.1M | 9.85M | 642.3M | 260.3M | 139.5M | 62.0M | 75.2M |
| Total debt | 376.1M | 627.0M | 586.0M | 539.0M | 236.8M | 650.7M | 333.5M | 162.8M | 87.8M | 149.2M |
| Total liabilities | 1.41B | 1.19B | 1.15B | 1.09B | 906.3M | 1.29B | 1.03B | 1.05B | 688.6M | 635.7M |
| Shareholders' equity | 1.20B | 1.32B | 1.28B | 1.21B | 1.29B | 1.11B | 1.38B | 1.50B | 1.82B | 1.71B |
| Shares outstanding | 54.6M | 54.3M | 53.9M | 53.6M | 53.3M | 48.7M | 48.4M | 48.2M | 48.3M | 48.0B |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 254.3M | 183.0M | 74.9M | 69.9M | 102.5M | -79.4M | -91.1M | 120.5M | 91.3M | 90.2M |
| Capital spending | -81.0M | -47.1M | -35.0M | -26.5M | -25.5M | -35.0M | -24.7M | -37.2M | -32.9M | -38.4M |
| Free cash flow | 173.3M | 135.9M | 39.9M | 43.4M | 77.1M | -114.4M | -115.8M | 83.3M | 58.4M | 51.8M |
| Cash from investing | -72.9M | -48.2M | -40.3M | -38.4M | 36.9M | -41.8M | -41.3M | -120.6M | -52.9M | -44.5M |
| Cash from financing | -285.7M | 18.6M | 21.5M | 280.1M | -181.5M | 310.8M | 146.6M | -42.3M | 11.3M | -118.0M |
| Dividends paid | -4.84M | 0 | 0 | |||||||
| Share buybacks | -4.43M | -8.44M | -7.50M | -8.70M | -12.9M | 0 | 0 | -50.0M | 0 | -54.5M |
| Change in cash | -88.0M | 145.7M | 62.3M | 307.6M | -44.8M | 191.7M | 13.9M | -46.4M | 53.8M | -72.8M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Nov 13, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 12, 2026 | Other filings | SEC |
| SCHEDULE 13G · Big-stake notice | Nov 10, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 5, 2026 | Big-stake notice | SEC |
| IRANNOTICE | Nov 4, 2026 | Other filings | SEC |
| 10-Q · Quarterly report | Nov 4, 2026 | Quarterly report | SEC |
| 8-K · Current report | Nov 4, 2026 | Results | SEC |
| 4 · Change in ownership | Sep 16, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 14, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 10, 2026 | Other filings | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Sep 8, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 4, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Sep 2, 2026 | Other filings | SEC |
| 4 · Change in ownership | Sep 2, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Sep 2, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 31, 2026 | Other filings | SEC |
| 4 · Change in ownership | Aug 13, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 11, 2026 | Other filings | SEC |
| SCHEDULE 13G · Big-stake notice | Aug 6, 2026 | Big-stake notice | SEC |
| IRANNOTICE | Aug 5, 2026 | Other filings | SEC |
| 10-Q · Quarterly report | Aug 5, 2026 | Quarterly report | SEC |
| 3 · Initial statement of ownership | Aug 5, 2026 | Insider trade | SEC |
| 8-K · Current report | Aug 5, 2026 | Results | SEC |
| 4 · Change in ownership | Jun 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 17, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 15, 2026 | Other filings | SEC |
| 3 · Initial statement of ownership | Jun 11, 2026 | Insider trade | SEC |
| 8-K · Current report | Jun 11, 2026 | Meeting outcome | SEC |
| SD · Specialized disclosure | May 29, 2026 | ESG report | SEC |
| 4 · Change in ownership | May 27, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | May 26, 2026 | Other filings | SEC |
| IRANNOTICE | May 6, 2026 | Other filings | SEC |
| 10-Q · Quarterly report | May 6, 2026 | Quarterly report | SEC |
| 8-K · Current report | May 6, 2026 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Apr 30, 2026 | Big-stake notice | SEC |
| ARS · Annual report to shareholders | Apr 29, 2026 | Annual report | SEC |
| DEFA14A · Additional proxy material | Apr 29, 2026 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 29, 2026 | Meeting notice | SEC |
| 4 · Change in ownership | Apr 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 13, 2026 | Insider trade | SEC |
| IRANNOTICE | Feb 25, 2026 | Other filings | SEC |
| 10-K · Annual report | Feb 25, 2026 | Annual report | SEC |
| 8-K · Current report | Feb 25, 2026 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 12, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 9, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Jan 14, 2026 | Management or board change | SEC |
| 4 · Change in ownership | Dec 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 19, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 18, 2025 | Other filings | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 6, 2025 | Big-stake notice | SEC |
| IRANNOTICE | Nov 5, 2025 | Other filings | SEC |
| 10-Q · Quarterly report | Nov 5, 2025 | Quarterly report | SEC |
| 8-K · Current report | Nov 5, 2025 | Results | SEC |
| 4 · Change in ownership | Sep 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 17, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | Sep 4, 2025 | Insider trade | SEC |
| 8-K · Current report | Sep 4, 2025 | Management or board change | SEC |
| 4 · Change in ownership | Aug 27, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 25, 2025 | Other filings | SEC |
| IRANNOTICE | Aug 6, 2025 | Other filings | SEC |
| 10-Q · Quarterly report | Aug 6, 2025 | Quarterly report | SEC |
| 8-K · Current report | Aug 6, 2025 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Jul 18, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Jun 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 17, 2025 | Insider trade | SEC |
| S-8 · Registration statement for employee plans | Jun 12, 2025 | Offer document | SEC |
| 8-K · Current report | Jun 11, 2025 | Management or board change | SEC |
| SD · Specialized disclosure | May 29, 2025 | ESG report | SEC |
| 8-K · Current report | May 21, 2025 | Current report | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 13, 2025 | Big-stake notice | SEC |
| IRANNOTICE | May 7, 2025 | Other filings | SEC |
| 10-Q · Quarterly report | May 7, 2025 | Quarterly report | SEC |
| 8-K · Current report | May 7, 2025 | Results | SEC |
| ARS · Annual report to shareholders | Apr 30, 2025 | Annual report | SEC |
| DEFA14A · Additional proxy material | Apr 30, 2025 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 30, 2025 | Meeting notice | SEC |
| 4 · Change in ownership | Apr 1, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 1, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 1, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 1, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 1, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 1, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 1, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 1, 2025 | Insider trade | SEC |
| 8-K · Current report | Mar 17, 2025 | Current report | SEC |
| IRANNOTICE | Feb 25, 2025 | Other filings | SEC |
| 10-K · Annual report | Feb 25, 2025 | Annual report | SEC |
| 8-K · Current report | Feb 25, 2025 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 13, 2025 | Big-stake notice | SEC |
| 3 · Initial statement of ownership | Jan 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 17, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Dec 17, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Dec 17, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Dec 17, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Dec 17, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Dec 13, 2024 | Insider trade | SEC |
| 144 · Notice of proposed sale | Dec 11, 2024 | Other filings | SEC |
| 144 · Notice of proposed sale | Dec 10, 2024 | Other filings | SEC |
| 8-K · Current report | Nov 1, 2024 | Current report | SEC |
| IRANNOTICE | Oct 30, 2024 | Other filings | SEC |
| 10-Q · Quarterly report | Oct 30, 2024 | Quarterly report | SEC |
| 8-K · Current report | Oct 30, 2024 | Results | SEC |
| 3 · Initial statement of ownership | Oct 15, 2024 | Insider trade | SEC |
| 8-K · Current report | Oct 8, 2024 | Management or board change | SEC |
| 4 · Change in ownership | Sep 17, 2024 | Insider trade | SEC |
| 3/A · Initial statement of ownership, amended | Sep 17, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Sep 13, 2024 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 11, 2024 | Other filings | SEC |
| 8-K · Current report | Sep 10, 2024 | Management or board change | SEC |
| 3 · Initial statement of ownership | Aug 9, 2024 | Insider trade | SEC |
| IRANNOTICE | Aug 1, 2024 | Other filings | SEC |
| 10-Q · Quarterly report | Aug 1, 2024 | Quarterly report | SEC |
| 8-K · Current report | Jul 31, 2024 | Results | SEC |
| 4 · Change in ownership | Jun 18, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 18, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 18, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 18, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 18, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 18, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 18, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 18, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 18, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 18, 2024 | Insider trade | SEC |
| S-8 · Registration statement for employee plans | Jun 12, 2024 | Offer document | SEC |
| 8-K · Current report | Jun 12, 2024 | Management or board change | SEC |
| DEFA14A · Additional proxy material | Jun 5, 2024 | Meeting notice | SEC |
| 4 · Change in ownership | Jun 5, 2024 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 3, 2024 | Other filings | SEC |
| SD · Specialized disclosure | May 30, 2024 | ESG report | SEC |
| 3 · Initial statement of ownership | May 17, 2024 | Insider trade | SEC |
| IRANNOTICE | May 3, 2024 | Other filings | SEC |
| 10-Q · Quarterly report | May 3, 2024 | Quarterly report | SEC |
| 8-K · Current report | May 1, 2024 | Results | SEC |
| ARS · Annual report to shareholders | Apr 26, 2024 | Annual report | SEC |
| DEFA14A · Additional proxy material | Apr 26, 2024 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 26, 2024 | Meeting notice | SEC |
| SC 13G · Big-stake notice | Apr 17, 2024 | Big-stake notice | SEC |
| 4 · Change in ownership | Apr 2, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Apr 2, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Apr 2, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Apr 2, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Apr 2, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Apr 2, 2024 | Insider trade | SEC |
| 3 · Initial statement of ownership | Mar 11, 2024 | Insider trade | SEC |
| 8-K · Current report | Mar 8, 2024 | Material contract | SEC |
| 8-K · Current report | Mar 5, 2024 | Current report | SEC |
| 3 · Initial statement of ownership | Mar 4, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2024 | Insider trade | SEC |
| 8-K · Current report | Mar 4, 2024 | Current report | SEC |
| IRANNOTICE | Feb 29, 2024 | Other filings | SEC |
| 10-K · Annual report | Feb 29, 2024 | Annual report | SEC |
| 8-K · Current report | Feb 21, 2024 | Results | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 12, 2024 | Big-stake notice | SEC |
| 8-K · Current report | Feb 5, 2024 | Management or board change | SEC |
| SC 13G/A · Big-stake notice, amended | Jan 23, 2024 | Big-stake notice | SEC |
| 8-K · Current report | Jan 8, 2024 | Current report | SEC |
| 4 · Change in ownership | Jan 3, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Dec 19, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Dec 19, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Dec 19, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Dec 19, 2023 | Insider trade | SEC |
| 8-K · Current report | Dec 13, 2023 | Current report | SEC |
| 8-K · Current report | Dec 6, 2023 | Current report | SEC |
| 8-K · Current report | Nov 20, 2023 | Current report | SEC |
| IRANNOTICE | Nov 1, 2023 | Other filings | SEC |
| 10-Q · Quarterly report | Nov 1, 2023 | Quarterly report | SEC |
| 8-K · Current report | Nov 1, 2023 | Results | SEC |
| 8-K · Current report | Oct 19, 2023 | Management or board change | SEC |
| 4 · Change in ownership | Oct 17, 2023 | Insider trade | SEC |
| 3 · Initial statement of ownership | Oct 13, 2023 | Insider trade | SEC |
| 8-K · Current report | Oct 6, 2023 | Management or board change | SEC |
| 8-K/A · Current report, amended | Sep 21, 2023 | Management or board change | SEC |
| 8-K · Current report | Sep 21, 2023 | Current report | SEC |
| 4 · Change in ownership | Sep 19, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Sep 19, 2023 | Insider trade | SEC |
| S-8 · Registration statement for employee plans | Jul 26, 2023 | Offer document | SEC |
This page holds 200 of 957 filings. Open Filings
Cap table
Built by 6ix from LivaNova PLC’s releases
- Common shares
- 55,086,809
- Fully diluted
- 55,086,809
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 55,086,809 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 55,086,809 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Andrea Lynn Saia Other companies: Outset Medical, Inc. (Director · Since at least Mar 23, 2021); Align Technology, Inc. (Director · Since at least Jul 25, 2013); Coca-Cola Enterprises Inc (Director · Jun 7, 2012 – Mar 31, 2016 · Past) | Director · Jul 27, 2016 – Dec 31, 2023 · Past |
| Donald Zurbay Other companies: Sight Sciences, Inc. (Director · Since at least Jun 4, 2026); Dentsply Sirona Inc. (Director · Since at least Jan 13, 2026) | Director · Since at least Sep 4, 2025 |
| Susan Podlogar Other companies: Tevogen Bio Holdings Inc. (Director · Since at least Feb 14, 2024); MetLife, Inc. (EVP & Chief HR Officer · Dec 20, 2022 – Mar 1, 2024 · Past) | Director since 2024 · Since at least Oct 8, 2024 |
| William Kozy Other companies: The Cooper Companies, Inc. (Director · Apr 1, 2016 – Apr 1, 2025 · Past); Becton, Dickinson and Company (Executive Vice President · Jan 27, 2006 – Dec 9, 2015 · Past) | Chair of the Board · Since at least Jun 12, 2018 |
| David S Wise Other companies: Cyberonics Inc (SR VP & Chief Admin Officer · Jun 8, 2009 – Oct 19, 2015 · Past) | Chief Administrative Officer · Oct 19, 2015 – Jan 15, 2019 · Past |
| Thad Huston Other companies: Artiva Biotherapeutics, Inc. (Chief Financial Officer and Award of Inducement Grant · Since at least Feb 18, 2026) | Chief Financial Officer · May 20, 2017 – May 23, 2020 · Past |
| Todd C. Schermerhorn Other companies: The Travelers Companies, Inc. (Director · Since at least Feb 4, 2020) | Director since 2020 · Since at least Dec 2, 2020 |
| Ahmet Tezel | Chief Innovation Officer · Since at least May 13, 2024 |
| Alex Shvartsburg | Chief Financial Officer · Since at least Apr 1, 2026 |
| Anne Liddy | Chief Legal Officer · Since at least Jun 5, 2026 |
All 33 people
| Person | Seat |
|---|---|
| Briana Gotlin | Vice President, Investor Relations · Since at least May 6, 2026 |
| Brooke Story | Director since 2022 · Since at least Jun 11, 2026 |
| Daniel Jeffrey Moore | Director · Jun 3, 2024 – Jun 3, 2024 · Past |
| Deanna Wilke | VP, Corporate Communications · Since at least Jun 11, 2026 |
| Francesco Bianchi | Director since 2015 · Since at least Jun 11, 2026 |
| Franco Poletti | President, Cardiopulmonary · Since at least Aug 1, 2024 |
| James Christopher Barry | Director · Since at least Oct 6, 2023 |
| J. Christopher Barry | Director since 2023 · Since at least Nov 5, 2026 |
| Jette Nygaard-Andersen | Director since 2026 · Since at least Jun 11, 2026 |
| Lucile Blaise | Global Head of Commercialization, Obstructive Sleep Apnea · Since at least Dec 2, 2025 |
| Michel Darnaud | President Cardiac Surgery · Oct 19, 2015 – Jul 27, 2016 · Past |
| Natalia Kozmina | Chief Human Resources Officer · Since at least Jan 6, 2025 |
| Peter Wilver | Director · Since at least Jun 11, 2026 |
| Philip Kowalczyk | Chief Strategy and Corporate Development Officer · Since at least Sep 3, 2026 |
| Rosario Bifulco | Director · Oct 19, 2015 – Oct 19, 2015 · Past |
| Roy Khoury | President, International · Jan 10, 2020 – Mar 1, 2021 · Past |
| Seng Stacy Enxing | Director · Since at least Jun 15, 2022 |
| Stacy Enxing Seng | Director since 2019 · Since at least Jun 11, 2026 |
| Stefano Di Lullo | Pres Cardiac Rhythm Mgmt · Oct 19, 2015 – Jul 27, 2016 · Past |
| Stefano Folli | President, Cardiopulmonary · Since at least May 21, 2026 |
| Stephanie Bolton | President, Global Epilepsy · Since at least Mar 1, 2024 |
| Sujay Mashru | Senior Vice President, APAC and Growth Markets · Since at least Nov 5, 2026 |
| Vladimir Makatsaria | Chief Executive Officer, Director · Since at least Mar 1, 2024 |
Log in to ask 6ix AI your own questions about LivaNova PLC.